Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

We studied 190 patients with smoldering multiple myeloma (SMM) at our institution between 1973 and 2014. Evolving change in monoclonal protein level (eMP) was defined as ⩾10% increase in serum monoclonal protein (M) and/or immunoglobulin (Ig) (M/Ig) within the first 6 months of diagnosis (only if M-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravi, P, Kumar, S, Larsen, J T, Gonsalves, W, Buadi, F, Lacy, M Q, Go, R, Dispenzieri, A, Kapoor, P, Lust, J A, Dingli, D, Lin, Y, Russell, S J, Leung, N, Gertz, M A, Kyle, R A, Bergsagel, P L, Rajkumar, S V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030386/
https://www.ncbi.nlm.nih.gov/pubmed/27471870
http://dx.doi.org/10.1038/bcj.2016.65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030386/
https://www.ncbi.nlm.nih.gov/pubmed/27471870
http://dx.doi.org/10.1038/bcj.2016.65

Ejemplares similares